Michael Lincoff, Cleveland Clilnic, Cleveland Ohio American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta The full picture of how bivalirudin is emerging as a treatment wi
Michael Lincoff, Cleveland Clilnic, Cleveland OhioAmerican College of Cardiology Annual Scientific Session March 11-14, 2006, AtlantaThe full picture of how bivalirudin is emerging as a treatment without also using glycoprotein IIb/IIIa inhibition in cases of acute coronary syndrome was painted at the Atlanta meeting by Michael Lincoff from the Cleveland Clinic.
Related Episodes
Bivalirudin For Angioplasty: Expensive Heparin?
Tony Gershlick Tony Gershlick, University of Leicester Adnan Kastrati, Deutsches Herzzentrum, Munich Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing deat
Remove Thrombus Before Primary Angioplasty!
Felix Zijlstra Felix Zijlstra, University Medical Center Groningen, The Netherlands Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits,
Heart Failure Drug Prevents Renal Damage?
Barry Massie Barry Massie, San Francisco VA Medical Center COMMENT: Aaron Kugelmass, Henry Ford Hospital, Detroit The adenosine A1-receptor antagonist rolofylline appears to prevent renal impairment a